Chlorine in PDB 4e2j: X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment
Protein crystallography data
The structure of X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment, PDB code: 4e2j
was solved by
J.A.Kohn,
K.Deshpande,
E.A.Ortlund,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.19 /
2.50
|
Space group
|
P 61
|
Cell size a, b, c (Å), α, β, γ (°)
|
104.356,
104.356,
143.925,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
20.5 /
25.5
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment
(pdb code 4e2j). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment, PDB code: 4e2j:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 4e2j
Go back to
Chlorine Binding Sites List in 4e2j
Chlorine binding site 1 out
of 4 in the X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl302
b:59.6
occ:1.00
|
CL25
|
A:MOF302
|
0.0
|
59.6
|
1.0
|
C19
|
A:MOF302
|
1.8
|
52.9
|
1.0
|
C15
|
A:MOF302
|
2.6
|
53.3
|
1.0
|
C14
|
A:MOF302
|
2.7
|
53.0
|
1.0
|
C24
|
A:MOF302
|
2.7
|
50.2
|
1.0
|
C29
|
A:MOF302
|
3.0
|
49.4
|
1.0
|
C20
|
A:MOF302
|
3.1
|
51.5
|
1.0
|
C6
|
A:MOF302
|
3.1
|
54.0
|
1.0
|
C30
|
A:MOF302
|
3.1
|
48.8
|
1.0
|
C7
|
A:MOF302
|
3.2
|
53.6
|
1.0
|
CE1
|
A:PHE92
|
3.3
|
35.5
|
1.0
|
C32
|
A:MOF302
|
3.5
|
48.6
|
1.0
|
C26
|
A:MOF302
|
3.6
|
50.1
|
1.0
|
C33
|
A:MOF302
|
3.6
|
49.2
|
1.0
|
C2
|
A:MOF302
|
3.8
|
55.6
|
1.0
|
CD1
|
A:PHE92
|
3.8
|
35.3
|
1.0
|
C34
|
A:MOF302
|
3.8
|
48.7
|
1.0
|
O21
|
A:MOF302
|
4.0
|
52.5
|
1.0
|
C31
|
A:MOF302
|
4.1
|
48.6
|
1.0
|
O4
|
A:MOF302
|
4.1
|
58.0
|
1.0
|
CB
|
A:LEU32
|
4.2
|
38.3
|
1.0
|
C22
|
A:MOF302
|
4.2
|
55.4
|
1.0
|
CD1
|
A:LEU32
|
4.2
|
38.6
|
1.0
|
CZ
|
A:PHE92
|
4.3
|
35.6
|
1.0
|
C9
|
A:MOF302
|
4.4
|
54.2
|
1.0
|
CD2
|
A:LEU32
|
4.5
|
38.1
|
1.0
|
CG
|
A:LEU32
|
4.5
|
38.3
|
1.0
|
SD
|
A:MET115
|
4.5
|
44.0
|
1.0
|
C1
|
A:MOF302
|
4.6
|
57.2
|
1.0
|
O35
|
A:MOF302
|
4.8
|
48.3
|
1.0
|
C8
|
A:MOF302
|
4.9
|
55.2
|
1.0
|
O
|
A:LEU32
|
5.0
|
37.7
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 4e2j
Go back to
Chlorine Binding Sites List in 4e2j
Chlorine binding site 2 out
of 4 in the X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl302
b:80.7
occ:1.00
|
CL18
|
A:MOF302
|
0.0
|
80.7
|
1.0
|
C12
|
A:MOF302
|
1.8
|
66.2
|
1.0
|
C5
|
A:MOF302
|
2.7
|
61.1
|
1.0
|
O13
|
A:MOF302
|
2.8
|
61.5
|
1.0
|
CZ
|
A:PHE218
|
3.3
|
49.0
|
1.0
|
CG2
|
A:THR208
|
3.6
|
52.0
|
1.0
|
CB
|
A:THR208
|
3.7
|
51.7
|
1.0
|
ND2
|
A:ASN33
|
3.7
|
43.3
|
1.0
|
CE2
|
A:PHE218
|
3.8
|
47.8
|
1.0
|
OD1
|
A:ASN33
|
3.9
|
41.7
|
1.0
|
OG1
|
A:THR208
|
4.0
|
52.1
|
1.0
|
CE
|
A:MET29
|
4.0
|
63.5
|
1.0
|
C1
|
A:MOF302
|
4.0
|
57.2
|
1.0
|
C8
|
A:MOF302
|
4.2
|
55.2
|
1.0
|
CE1
|
A:PHE218
|
4.2
|
48.9
|
1.0
|
CG
|
A:ASN33
|
4.3
|
42.2
|
1.0
|
CG1
|
A:VAL216
|
4.3
|
52.5
|
1.0
|
C2
|
A:MOF302
|
4.5
|
55.6
|
1.0
|
CA
|
A:CYS205
|
4.6
|
42.6
|
1.0
|
C7
|
A:MOF302
|
4.6
|
53.6
|
1.0
|
O4
|
A:MOF302
|
4.7
|
58.0
|
1.0
|
O
|
A:CYS205
|
4.8
|
43.4
|
1.0
|
O17
|
A:MOF302
|
4.8
|
56.7
|
1.0
|
CG
|
A:MET29
|
4.9
|
58.8
|
1.0
|
CB
|
A:MET29
|
5.0
|
54.7
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 4e2j
Go back to
Chlorine Binding Sites List in 4e2j
Chlorine binding site 3 out
of 4 in the X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl301
b:51.2
occ:1.00
|
CL25
|
B:MOF301
|
0.0
|
51.2
|
1.0
|
C19
|
B:MOF301
|
1.8
|
47.0
|
1.0
|
C15
|
B:MOF301
|
2.6
|
47.4
|
1.0
|
C14
|
B:MOF301
|
2.7
|
46.2
|
1.0
|
C24
|
B:MOF301
|
2.7
|
45.6
|
1.0
|
C29
|
B:MOF301
|
3.0
|
45.0
|
1.0
|
C6
|
B:MOF301
|
3.0
|
47.4
|
1.0
|
C30
|
B:MOF301
|
3.1
|
44.6
|
1.0
|
C20
|
B:MOF301
|
3.1
|
45.2
|
1.0
|
C7
|
B:MOF301
|
3.1
|
48.0
|
1.0
|
CE1
|
B:PHE92
|
3.2
|
34.2
|
1.0
|
C32
|
B:MOF301
|
3.5
|
44.2
|
1.0
|
C33
|
B:MOF301
|
3.6
|
45.3
|
1.0
|
C26
|
B:MOF301
|
3.6
|
45.6
|
1.0
|
CD1
|
B:PHE92
|
3.7
|
33.6
|
1.0
|
C2
|
B:MOF301
|
3.7
|
48.4
|
1.0
|
C34
|
B:MOF301
|
3.8
|
45.5
|
1.0
|
O21
|
B:MOF301
|
3.9
|
48.0
|
1.0
|
CB
|
B:LEU32
|
4.0
|
31.6
|
1.0
|
O4
|
B:MOF301
|
4.1
|
51.9
|
1.0
|
CD1
|
B:LEU32
|
4.1
|
31.2
|
1.0
|
C31
|
B:MOF301
|
4.1
|
43.2
|
1.0
|
CZ
|
B:PHE92
|
4.3
|
34.3
|
1.0
|
CD2
|
B:LEU32
|
4.3
|
31.4
|
1.0
|
CG
|
B:LEU32
|
4.4
|
31.2
|
1.0
|
C22
|
B:MOF301
|
4.4
|
51.6
|
1.0
|
C9
|
B:MOF301
|
4.4
|
47.4
|
1.0
|
C1
|
B:MOF301
|
4.6
|
50.6
|
1.0
|
SD
|
B:MET115
|
4.6
|
39.4
|
1.0
|
O35
|
B:MOF301
|
4.8
|
46.2
|
1.0
|
C8
|
B:MOF301
|
4.9
|
47.1
|
1.0
|
CG
|
B:PHE92
|
5.0
|
34.0
|
1.0
|
O
|
B:LEU32
|
5.0
|
33.8
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 4e2j
Go back to
Chlorine Binding Sites List in 4e2j
Chlorine binding site 4 out
of 4 in the X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 Ligand Binding Domain in Complex with Mometasone Furoate and Tif-2 Coactivator Fragment within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl301
b:74.2
occ:1.00
|
CL18
|
B:MOF301
|
0.0
|
74.2
|
1.0
|
C12
|
B:MOF301
|
1.8
|
55.8
|
1.0
|
C5
|
B:MOF301
|
2.7
|
53.9
|
1.0
|
O17
|
B:MOF301
|
2.8
|
52.5
|
1.0
|
OG1
|
B:THR208
|
3.0
|
41.1
|
1.0
|
CE
|
B:MET29
|
3.2
|
38.3
|
0.5
|
O13
|
B:MOF301
|
3.3
|
54.5
|
1.0
|
CB
|
B:PHE204
|
3.4
|
41.0
|
1.0
|
O
|
B:PHE204
|
3.5
|
38.5
|
1.0
|
C
|
B:PHE204
|
3.7
|
38.6
|
1.0
|
C1
|
B:MOF301
|
3.7
|
50.6
|
1.0
|
C11
|
B:MOF301
|
3.8
|
52.4
|
1.0
|
C10
|
B:MOF301
|
3.9
|
47.8
|
1.0
|
C3
|
B:MOF301
|
4.0
|
49.4
|
1.0
|
CA
|
B:PHE204
|
4.1
|
39.3
|
1.0
|
CB
|
B:THR208
|
4.1
|
39.7
|
1.0
|
CD1
|
B:PHE204
|
4.1
|
43.9
|
1.0
|
CG
|
B:PHE204
|
4.1
|
42.8
|
1.0
|
O4
|
B:MOF301
|
4.2
|
51.9
|
1.0
|
NE2
|
B:GLN111
|
4.2
|
45.1
|
1.0
|
N
|
B:CYS205
|
4.3
|
37.4
|
1.0
|
CG
|
B:GLN111
|
4.5
|
45.3
|
1.0
|
SD
|
B:MET29
|
4.7
|
37.5
|
0.5
|
CG2
|
B:THR208
|
4.7
|
39.4
|
1.0
|
CA
|
B:CYS205
|
4.7
|
36.4
|
1.0
|
CD
|
B:GLN111
|
4.9
|
45.9
|
1.0
|
CE
|
B:MET29
|
4.9
|
41.7
|
0.5
|
|
Reference:
J.A.Kohn,
K.Deshpande,
E.A.Ortlund.
Deciphering Modern Glucocorticoid Cross-Pharmacology Using Ancestral Corticosteroid Receptors. J.Biol.Chem. V. 287 16267 2012.
ISSN: ISSN 0021-9258
PubMed: 22437833
DOI: 10.1074/JBC.M112.346411
Page generated: Sun Jul 21 12:29:10 2024
|